文献速递复苏、休克与脓毒症心脑血管急症

急诊呼吸心跳骤停临床路径管理患者的临床实践与评价

[Clinical practice and evaluation of management of patients based on clinical pathway of emergency respiratory and cardiac arrest].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论回顾性分析显示,急诊呼吸心跳骤停临床路径可缩短除颤、深静脉置管、去甲肾上腺素使用及血标本送检时间(均P<0.05),但ROSC成功率无显著差异。

该研究回顾性分析复旦大学附属华山医院北院实施急诊呼吸心跳骤停临床路径前后各1年的患者数据,观察组(2017年7月至2018年6月)按临床路径管理,对照组(2016年7月至2017年6月)按2015年美国心脏协会心肺复苏与心血管急救指南更新及急诊重点病种管理流程人工管理。结果显示临床路径可有效指导急诊医护人员决策,显著减少复苏流程变异,首次除颤时间、深静脉置管完成时间、去甲肾上腺素使用时间、血标本送检完成时间均显著缩短(均P<0.05)。但心肺复苏启动时间、气管插管完成时间、外周静脉通路时间、首剂肾上腺素及碳酸氢钠使用时间、ROSC成功率两组无显著差异。作者认为临床路径可提高复苏质量并保障急诊医疗安全。

要点

  • 临床路径组首次除颤时间1.28±0.86分钟 vs 对照组2.93±1.61分钟,显著缩短(P<0.05)。
  • 临床路径组深静脉置管完成时间15.13±2.73分钟 vs 对照组17.25±3.02分钟,显著缩短(P<0.05)。
  • 临床路径组去甲肾上腺素使用时间15.43±2.80分钟 vs 对照组17.88±1.67分钟,显著缩短(P<0.05)。
  • 临床路径组血标本送检完成时间7.81±1.42分钟 vs 对照组9.00±1.03分钟,显著缩短(P<0.05)。
  • ROSC成功率临床路径组15.04%(17/113) vs 对照组12.50%(12/96),差异无统计学意义(P>0.05)。

适用人群与场景

  • 复旦大学附属华山医院北院收治的突发呼吸心跳骤停患者,观察组为2017年7月至2018年6月按急诊呼吸心跳骤停临床路径管理者,对照组为2016年7月至2017年6月按2015年美国心脏协会心肺复苏与心血管急救指南更新及急诊重点病种管理流程人工管理者。

处置流程与药物剂量

  • 观察组按急诊呼吸心跳骤停临床路径管理,对照组按2015年美国心脏协会心肺复苏与心血管急救指南更新及急诊重点病种管理流程人工管理。
  • 临床路径可有效指导急诊医护人员决策,减少复苏流程变异。

研究设计与关键结果

  • 研究类型为回顾性分析,比较实施急诊呼吸心跳骤停临床路径前后各1年的患者数据,观察组113例,对照组96例。
  • 两组性别、年龄、基础疾病差异无统计学意义。
  • 首次除颤时间:观察组1.28±0.86分钟 vs 对照组2.93±1.61分钟,P<0.05。
  • 深静脉置管完成时间:观察组15.13±2.73分钟 vs 对照组17.25±3.02分钟,P<0.05。
  • 去甲肾上腺素使用时间:观察组15.43±2.80分钟 vs 对照组17.88±1.67分钟,P<0.05。
  • 血标本送检完成时间:观察组7.81±1.42分钟 vs 对照组9.00±1.03分钟,P<0.05。
  • 心肺复苏启动时间、气管插管完成时间、外周静脉通路时间、首剂肾上腺素及碳酸氢钠使用时间、ROSC成功率两组差异无统计学意义(均P>0.05);首剂肾上腺素使用时间观察组3.81±1.22分钟 vs 对照组4.00±1.32分钟,碳酸氢钠使用时间观察组8.94±3.49分钟 vs 对照组11.19±3.54分钟;ROSC成功率观察组15.04%(17/113) vs 对照组12.50%(12/96)。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为急诊呼吸心跳骤停临床路径可有效指导急诊医护人员临床决策,显著减少复苏流程变异,提高复苏质量,保障急诊医疗安全。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the effect of clinical pathway of emergency respiratory and cardiac arrest on management of patients with sudden respiratory and cardiac arrest.

METHODS: The clinical data of patients with sudden respiratory and cardiac arrest admitted to Huashan North Hospital Affiliated to Fudan University from 1 year before to 1 year (started in July 2017) after the implementation of clinical pathway of emergency respiratory and cardiac arrest were retrospectively analyzed. The patients who managed by clinical pathway of emergency respiratory and cardiac arrest (from July 2017 to June 2018) were served as observational group, and those manually managed by 2015 American Heart Association cardiopulmonary resuscitation and cardiovascular emergency guide update and the procession in the management of emergency key diseases (from July 2016 to June 2017) were set as control group. The gender, age, underlying disease, the initiation time of cardiopulmonary resuscitation (CPR), the first time of defibrillation, the completion time of endotracheal intubation, the time of venous access, the usage time of the first dose of adrenaline, the usage time of vasoactive drugs, the completion rate of high quality CPR, the success rate of return of spontaneous circulation (ROSC) and the table procedure of clinical pathway were compared between the two groups.

RESULTS: There was no statistically significant difference in gender, age or underlying disease between the two groups. Compared with the control group, the clinical pathway could effectively guide the decision-making of the emergency medical staffs, significantly reduce the variation in the procession of the resuscitation, the first time of defibrillation, the completion time of the deep vein catheterization, the usage time of norepinephrine and the completion time of the blood specimen delivery were significantly shortened [the first time of defibrillation (minutes): 1.28±0.86 vs. 2.93±1.61, the completion time of deep vein catheter (minutes): 15.13±2.73 vs. 17.25±3.02, the usage time of norepinephrine (minutes): 15.43±2.80 vs. 17.88±1.67, the completion time of blood specimen delivery (minutes): 7.81±1.42 vs. 9.00±1.03, all P < 0.05]. There was no statistically significant difference in the initiation time of CPR, the completion time of tracheal intubation, the time of peripheral venous access, the usage time of the first dose of adrenaline or sodium bicarbonate, or the success rate of ROSC between the two groups. However, the usage time of the first dose of adrenaline and sodium bicarbonate was shortened in the observation group [the usage time of the first dose of adrenaline (minutes): 3.81±1.22 vs. 4.00±1.32, the usage time of the first does of sodium bicarbonate (minutes): 8.94±3.49 vs. 11.19±3.54, both P > 0.05], and the success rate of ROSC was relatively increased as compared with those in the control group [15.04% (17/113) vs. 12.50% (12/96), P > 0.05].

CONCLUSIONS: The clinical pathway of emergency respiratory and cardiac arrest could effectively guide the clinical decision-making of the emergency medical staffs, significantly reduce the variation in the procession of the resuscitation, improve the quality of the resuscitation, and ensure medical safety of emergency department.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ge Z, Xia Z, Ma K, et al. [Clinical practice and evaluation of management of patients based on clinical pathway of emergency respiratory and cardiac arrest]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30914092. doi:10.3760/cma.j.issn.2095-4352.2019.03.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。